Search results
Jun 3, 2024 · Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology .
Apr 11, 2024 · But perhaps the most astonishing feature of biology is that it runs on digital code in the form of DNA, which makes it possible for us to imagine building such living machines. The code is made up of As, Ts, Cs, and Gs, and we can read and write it to program cells like we program computers.
Jun 3, 2024 · Ginkgo Bioworks’ Enzyme Intelligence suite of tools, equipped with AI-guided design and a vast proprietary protein database, engineered an enzyme achieving over 600% performance improvement. This leap in enzyme activity enabled our partner to establish sustainable and efficient production through fermentation, allowing them to meet their ...
Ginkgo Bioworks, Inc. | 88,878 followers on LinkedIn. Making biology easier to engineer. | At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to...
Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 15, 2024 · Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.
Aug 24, 2021 · The Boston genetic engineering company Ginkgo Bioworks and its CEO, Jason Kelly, have been spectacularly successful selling a story: that synthetic biology will transform the manufacture of ...
Aug 7, 2023 · After striking a deal centered on enzyme production last fall, Merck and Ginkgo have teamed up again in a biologic manufacturing collaboration worth up to $490 million.
Jan 21, 2020 · As co-founder of synthetic biology unicorn Ginkgo Bioworks, Reshma Shetty has helped enable the entire synthetic biology industry while inspiring a generation of new biological engineers.
